Spero Therapeutics
2 followers
Spero Therapeutics (Nasdaq: SPRO) is a multi-asset pre-commercial stage biopharmaceutical company in Cambridge, Mass. We are highly committed to advancing novel treatment approaches for bacterial infections with a world-class team of biotechnological and biopharmaceutical experts. The company has a... Read more
Org chart
Sath Shukla
President & CEO
Sath Shukla
Collapse
Esther Rajavelu
CFO & Chief Business Officer
Cristina Larkin
Chief Operating Officer
Kamal Hamed
Chief Medical Officer
Timothy Keutzer
Chief Development Officer
Jamie Brady
Chief Human Resources Officer
Thomas Parr
Chief Scientific Officer
David Musselman
SVP, Sales & Market Access
Jay Blackington
VP, People Strategy & Culture
Melissa Stundick
VP, Business Development
Michael Pucci
Executive Director, Early Drug Discovery
Terese Hoekstra
VP, Market Access
Troy Lister
VP, R&D
Akash Jain
Vice President, Alliance Management And Business Development
Susan Redican
Vice President, Head Of Clincal Operations
Kathy Burke
Executive Director & Head Market Access
Shekman Wong
Executive Director, Head Of Clinical Pharmacology, DMPK And Drug Analysis
Nivedita Bhatt
Senior Director
John C. Pottage
Director
Scott Jackson
Director
Tregoning Prior
Director
Frank E. Thomas
Director
Indu Lakhani
Director, Biostatistics & Statistical Programming
Hanna Kwak
Director
Ilia Terova
Director, CMC
Myriah Satterfield
Associate Director, Clinical Data Mangement
Laura McGinn
Senior Executive Assistant
Kristyn McCandless
Associate Director, Legal
Jennifer Marten
Senior Corporate Paralegal
Teams
View all
